We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -20.00 | -0.16% | 12,106.00 | 12,120.00 | 12,122.00 | 12,190.00 | 12,024.00 | 12,080.00 | 999,558 | 16:35:02 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.55 | 187.98B |
Hot Features
Premium
RNS Number:8452N
AstraZeneca PLC
23 July 2003
Announcement to LSE on Wednesday, 23 July 2003 at 9:00am.
AstraZeneca second quarter and first half year results 2003
Tomorrow, Thursday, 24 July 2003 AstraZeneca will be releasing its second
quarter and first half year results for 2003 at 11:00bst.
There will be an analyst teleconference at 13:00bst, 08:00 est, for which the
numbers are in the UK: 0800 559 3282, for Europe +44 (0)20 7984 7582 and for the
US: 866 239 0750. These numbers, as well as details of the replay facility
available through 4 August 2003, are on the Investor Relations part of the
AstraZeneca website at www.astrazeneca.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORNKBKKOBKDDOB
1 Year Astrazeneca Chart |
1 Month Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
